This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Intercept Pharmaceuticals, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Thomas Hensel: Innovator in Bile Acid Derivatives
Introduction
Thomas Hensel is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of bile acid derivatives. His innovative work has led to the development of methods and intermediates that are crucial for advancing medical treatments.
Latest Patents
Hensel holds a patent for "Methods and intermediates for the preparation of bile acid derivatives." This patent outlines novel methods and intermediates that are useful in the preparation of compounds that can be used as pharmaceutically acceptable salts, hydrates, or prodrugs. The patent specifically details the reaction of a compound with a halogenating reagent to produce a new compound, showcasing Hensel's expertise in chemical synthesis.
Career Highlights
Currently, Thomas Hensel is associated with Intercept Pharmaceuticals, Inc., where he continues to work on innovative pharmaceutical solutions. His career is marked by a commitment to research and development in the pharmaceutical industry, contributing to advancements that can improve patient outcomes.
Collaborations
Hensel has collaborated with esteemed colleagues such as Roberto Pellicciari and Antimo Gioiello. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to innovative solutions in the pharmaceutical field.
Conclusion
Thomas Hensel's contributions to the field of bile acid derivatives exemplify his dedication to innovation in pharmaceuticals. His work not only advances scientific knowledge but also has the potential to impact patient care positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
